Skip to main content
OpenTrials

Clinical trial condition

Central Nervous System Lymphoma

Explore clinical trials studying Central Nervous System Lymphoma. Study availability and eligibility vary by location and protocol.

35 public trials 13 recruiting studies
Refine in advanced search Browse all conditions

Central Nervous System Lymphoma trial results

Recruiting

Loncastuximab Tesirine and Rituximab Following Stereotactic Radiosurgery in Patients With Central Nervous System Lymphomas (SOLAR)

NCT06607549

Conditions
Central Nervous System Lymphoma
Locations
  • Sidney Kimmel Comprehensive Cancer Center at Jefferson Philadelphia, Pennsylvania, United States
  • Brown University Health Rhode Island Hospital Providence, Rhode Island, United States
  • Huntsman Cancer Institute at University of Utah Salt Lake City, Utah, United States
View Trial Details
Recruiting

Lentiviral Gene Therapy (Zamtocabtagene Autoleucel) LTFU

NCT06116110

Conditions
Central Nervous System Lymphoma, Hemic and Lymphatic Diseases, High Grade B-Cell Lymphoma, +14 more
Locations
  • Stanford University Stanford, California, United States
  • Yale University New Haven, Connecticut, United States
  • University of Maryland Marlene and Stewart Greenebaum Comprehensive Cancer Center Baltimore, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

A Study of Epcoritamab and Ibrutinib in People With Central Nervous System Lymphoma (CNSL)

NCT07082868

Conditions
Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma, Primary Central Nervous System Lymphoma (PCNSL), +4 more
Locations
  • Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities) Basking Ridge, New Jersey, United States
  • Memorial Sloan Kettering Monmouth (Limited Protocol Activities) Middletown, New Jersey, United States
  • Memorial Sloan Kettering Bergen (Limited Protocol Activities) Montvale, New Jersey, United States
  • Memorial Sloan Kettering Commack (Limited Protocol Activities) Commack, New York, United States
View Trial Details
Recruiting

DALY II USA/ MB-CART2019.1 for DLBCL

NCT04792489

Conditions
Central Nervous System Lymphoma, Central Nervous System Neoplasms, Hemic and Lymphatic Diseases, +22 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Mayo Clinic Phoenix, Arizona, United States
  • UC San Diego Health La Jolla, California, United States
View all 32 locations
View Trial Details
Recruiting

Selinexor in Combination With MTX+Ritu to Treat R/R CNSL

NCT05698147

Conditions
Central Nervous System Lymphoma
Locations
  • The First Affiliated Hospital Of Anhui Medical University Hefei, Anhui, China
  • Beijing Tiantan Hospital, Capital Medical University Beijing, Beijing Municipality, China
  • The First Affiliated Hospital Of Fujian Medical University Fuzhou, Fujian, China
  • Oncology Department of The First Affiliated Hospital of Zhengzhou University Zhengzhou, Henan, China
View Trial Details

Related conditions